BR0011678A - Composições farmacêuticas compreendendo complexos de metal - Google Patents
Composições farmacêuticas compreendendo complexos de metalInfo
- Publication number
- BR0011678A BR0011678A BR0011678-5A BR0011678A BR0011678A BR 0011678 A BR0011678 A BR 0011678A BR 0011678 A BR0011678 A BR 0011678A BR 0011678 A BR0011678 A BR 0011678A
- Authority
- BR
- Brazil
- Prior art keywords
- group
- mixture
- pharmaceutical compositions
- metal complexes
- ions
- Prior art date
Links
- 229910052751 metal Inorganic materials 0.000 title abstract 2
- 239000002184 metal Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 5
- 239000003446 ligand Substances 0.000 abstract 4
- -1 pseudohalide ion Chemical class 0.000 abstract 3
- 150000001768 cations Chemical group 0.000 abstract 2
- 229910021480 group 4 element Inorganic materials 0.000 abstract 2
- 229910021478 group 5 element Inorganic materials 0.000 abstract 2
- 229910021476 group 6 element Inorganic materials 0.000 abstract 2
- 229910021645 metal ion Inorganic materials 0.000 abstract 2
- 230000000737 periodic effect Effects 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000004820 halides Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F19/00—Metal compounds according to more than one of main groups C07F1/00 - C07F17/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0046—Ruthenium compounds
- C07F15/0053—Ruthenium compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12516699P | 1999-03-19 | 1999-03-19 | |
| PCT/CA2000/000294 WO2000056743A1 (en) | 1999-03-19 | 2000-03-17 | Pharmaceutical compositions comprising metal complexes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0011678A true BR0011678A (pt) | 2002-02-26 |
Family
ID=22418482
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0011678-5A BR0011678A (pt) | 1999-03-19 | 2000-03-17 | Composições farmacêuticas compreendendo complexos de metal |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20020049190A1 (enExample) |
| EP (1) | EP1163247A1 (enExample) |
| JP (1) | JP2004500321A (enExample) |
| KR (1) | KR20010112343A (enExample) |
| CN (1) | CN1391577A (enExample) |
| AU (1) | AU3268500A (enExample) |
| BR (1) | BR0011678A (enExample) |
| CA (1) | CA2367282A1 (enExample) |
| CZ (1) | CZ20013307A3 (enExample) |
| HU (1) | HUP0400457A2 (enExample) |
| IL (1) | IL145290A0 (enExample) |
| MX (1) | MXPA01009410A (enExample) |
| NO (1) | NO20014526L (enExample) |
| PL (1) | PL356683A1 (enExample) |
| WO (1) | WO2000056743A1 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL202731B1 (pl) | 1999-04-13 | 2009-07-31 | Anormed | Sposób wytwarzania kompleksu cis-platynowego oraz kompleks cis-platynowy |
| JP4227701B2 (ja) * | 1999-05-25 | 2009-02-18 | 中部キレスト株式会社 | ジエチレントリアミン五酢酸ルテニウム二アンモニウム塩またはその水和物およびその製法 |
| US6489638B2 (en) * | 2000-06-23 | 2002-12-03 | Semiconductor Energy Laboratory Co., Ltd. | Light emitting device |
| US6894049B1 (en) | 2000-10-04 | 2005-05-17 | Anormed, Inc. | Platinum complexes as antitumor agents |
| US20020072512A1 (en) * | 2000-12-08 | 2002-06-13 | Metaphore Pharmaceuticals, Inc | Method of preventing and treating HIV-mediated central nervous system damage |
| GB0111872D0 (en) | 2001-05-15 | 2001-07-04 | Northwick Park Inst For Medica | Therapeutic agents and methods |
| EP2042181A1 (en) | 2002-02-04 | 2009-04-01 | ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda. | Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases |
| GB2395431A (en) * | 2002-11-20 | 2004-05-26 | Northwick Park Inst For Medica | Combination of a metal carbonyl compound and a guanylate cyclase stimulant or stabilizer for the therapeutic delivery of carbon monoxide |
| GB2395432B (en) * | 2002-11-20 | 2005-09-14 | Northwick Park Inst For Medica | Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs |
| WO2005016270A2 (en) * | 2003-08-04 | 2005-02-24 | Galileo Pharmaceuticals, Inc. | Methods for treatment of dermatological conditions |
| ATE537141T1 (de) | 2004-02-05 | 2011-12-15 | Kyorin Seiyaku Kk | Bicycloesterderivat |
| FR2873037B1 (fr) * | 2004-07-13 | 2008-04-11 | Univ Pasteur | Methodes et compositions pour le traitement de cancers |
| JP5238511B2 (ja) * | 2005-12-21 | 2013-07-17 | エフ．ホフマン−ラ・ロッヒェ・アクチェンゲゼルシャフト | レドックスメディエータとしてのルテニウム錯体の使用、検知システム及びルテニウム錯体 |
| GB0601394D0 (en) | 2006-01-24 | 2006-03-01 | Hemocorm Ltd | Therapeutic delivery of carbon monoxide |
| AU2007224066B2 (en) | 2006-03-08 | 2011-10-27 | Kyorin Pharmaceutical Co., Ltd. | Method for producing aminoacetylpyrrolidinecarbonitrile derivative and production intermediate thereof |
| JP5564249B2 (ja) * | 2006-06-23 | 2014-07-30 | アレシア・バイオセラピューティクス・インコーポレーテッド | 癌に関与するポリヌクレオチド配列およびポリペプチド配列 |
| WO2008038305A2 (en) * | 2006-09-26 | 2008-04-03 | Jegannathan Srinivas | Therapeutical formulation comprising a thiazolidinedione and a nitric oxide scavenger. |
| ATE550319T1 (de) | 2007-03-22 | 2012-04-15 | Kyorin Seiyaku Kk | Verfahren zur herstellung eines aminoacetylpyrrolidincarbonitrilderivats |
| AU2009321508B2 (en) | 2008-11-03 | 2015-03-12 | Adc Therapeutics Sa | Antibodies that specifically block the biological activity of a tumor antigen |
| DE102010014412A1 (de) | 2010-04-08 | 2012-04-19 | Friedrich-Schiller-Universität Jena | Verwendung von zweikernigen Eisenkomplexen mit schwefelhaltigen Liganden als pharmakologische Wirkstoffe |
| DE102010014411A1 (de) | 2010-04-08 | 2011-10-13 | Friedrich-Schiller-Universität Jena | Kohlenmonoxid und Eisen freisetzende Moleküle, deren Verwendung und Verfahren zu deren Herstellung |
| CN106146664B (zh) | 2011-03-31 | 2021-09-07 | Adc治疗股份有限公司 | 针对肾相关抗原1的抗体及其抗原结合片段 |
| US9163044B2 (en) | 2011-04-19 | 2015-10-20 | Alfama, Inc. | Carbon monoxide releasing molecules and uses thereof |
| WO2013013179A1 (en) | 2011-07-21 | 2013-01-24 | Alfama, Inc. | Ruthenium carbon monoxide releasing molecules and uses thereof |
| CA3115623A1 (en) | 2012-01-09 | 2013-07-18 | Adc Therapeutics Sa | Method for treating breast cancer |
| DE102012004132A1 (de) | 2012-02-29 | 2013-08-29 | Friedrich-Schiller-Universität Jena | Kohlenstoffmonoxid freisetzende Materialien und deren Verwendung |
| DE102014008537A1 (de) | 2014-06-04 | 2015-12-17 | Friedrich-Schiller-Universität Jena | Wasserlösliche manganbasierte Kohlenstoffmonoxid freisetzende Moleküle, deren Verwendung und Verfahren zu deren Herstellung |
| EP3212610B1 (en) * | 2014-10-30 | 2020-10-28 | Katholieke Universiteit Leuven | Methods for low temperature fluorine-18 radiolabeling of biomolecules |
| CN113429456B (zh) * | 2021-06-11 | 2022-05-31 | 首都医科大学 | 多肽衍生物钌类络合物及其制备方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5112974A (en) * | 1985-01-18 | 1992-05-12 | The Trustees Of Columbia University In The City Of New York | Mixed ligand complexes and uses thereof as binding agents to DNA |
| US4721669A (en) * | 1985-01-18 | 1988-01-26 | The Trustees Of Columbia University In The City Of New York | Chemical probes for left-handed DNA and chiral metal complexes as Z-specific anti-tumor agents |
| GB9317686D0 (en) * | 1993-08-25 | 1993-10-13 | Johnson Matthey Plc | Pharmaceutical compositions |
| SE9703396D0 (sv) * | 1997-09-19 | 1997-09-19 | Lincoln | Binuclear complex |
-
2000
- 2000-03-17 HU HU0400457A patent/HUP0400457A2/hu unknown
- 2000-03-17 IL IL14529000A patent/IL145290A0/xx unknown
- 2000-03-17 EP EP00910468A patent/EP1163247A1/en not_active Withdrawn
- 2000-03-17 CA CA002367282A patent/CA2367282A1/en not_active Abandoned
- 2000-03-17 MX MXPA01009410A patent/MXPA01009410A/es unknown
- 2000-03-17 BR BR0011678-5A patent/BR0011678A/pt not_active Application Discontinuation
- 2000-03-17 CN CN00806748A patent/CN1391577A/zh active Pending
- 2000-03-17 PL PL00356683A patent/PL356683A1/xx not_active Application Discontinuation
- 2000-03-17 JP JP2000606604A patent/JP2004500321A/ja not_active Withdrawn
- 2000-03-17 WO PCT/CA2000/000294 patent/WO2000056743A1/en not_active Ceased
- 2000-03-17 KR KR1020017011819A patent/KR20010112343A/ko not_active Withdrawn
- 2000-03-17 AU AU32685/00A patent/AU3268500A/en not_active Abandoned
- 2000-03-17 US US09/527,450 patent/US20020049190A1/en not_active Abandoned
- 2000-03-17 CZ CZ20013307A patent/CZ20013307A3/cs unknown
-
2001
- 2001-09-18 NO NO20014526A patent/NO20014526L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1163247A1 (en) | 2001-12-19 |
| WO2000056743A1 (en) | 2000-09-28 |
| PL356683A1 (en) | 2004-06-28 |
| NO20014526D0 (no) | 2001-09-18 |
| CA2367282A1 (en) | 2000-09-28 |
| IL145290A0 (en) | 2002-06-30 |
| KR20010112343A (ko) | 2001-12-20 |
| CZ20013307A3 (cs) | 2002-05-15 |
| HUP0400457A2 (hu) | 2004-05-28 |
| CN1391577A (zh) | 2003-01-15 |
| JP2004500321A (ja) | 2004-01-08 |
| NO20014526L (no) | 2001-10-16 |
| US20020049190A1 (en) | 2002-04-25 |
| MXPA01009410A (es) | 2003-06-06 |
| AU3268500A (en) | 2000-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA01009410A (es) | Composiciones farmaceuticas que comprenden complejos de metal. | |
| ZA200007222B (en) | Glycopeptide derivatives and pharmaceutical compositions containing the same. | |
| KR900002784A (ko) | 항종양치료에 사용하기 위한 약제학적 결합제제 | |
| BR9303993A (pt) | Composto, processo para preparar o mesmo e composição farmacêutica | |
| HUP0102422A3 (en) | Isothiazole derivatives useful as anticancer agents, pharmaceutical compositions containing such compounds and processes for their preparation | |
| IL103301A0 (en) | Pyrimidine nucleoside derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| TW272195B (enExample) | ||
| IL73632A (en) | N-acylated substituted trans-1,2-diaminocyclohexane compounds,their preparation and pharmaceutical compositions containing them | |
| BRPI0215312B8 (pt) | composto, uso de um composto, composição farmacêutica, e processo para a preparação de um composto | |
| CA2111527A1 (en) | Phosphonooxymethyl Ethers of Taxane Derivatives | |
| ATE255129T1 (de) | Hemmer von apoptose | |
| BR0214038A (pt) | Composições catalisadoras de imino-amida para a polimerização de olefinas | |
| TW349094B (en) | Compositions and methods for controlling harmful fungi | |
| BG102673A (bg) | Смеси, добивани от зърна на еugеniа jамвоlаnа lамаrск, получаване и използване на посочените смеси и някои техни компоненти като лекарства | |
| GEP20032953B (en) | Antitumor Agents | |
| CA2186731A1 (en) | Trinuclear cationic platinum complexes having antitumour activity and pharmaceutical compositions containing them | |
| TW337982B (en) | Compositions and methods for controlling harmful fungi | |
| KR890014107A (ko) | 백금 화학 요법약제 | |
| CA2188798A1 (en) | Tryptamine Derivatives as 5-HT-1D Receptor Ligands | |
| ATE326450T1 (de) | Metallkomplexe und deren therapeutische verwendungen | |
| MA24721A1 (fr) | Compositions nouvelles renfermant des derives de benzopyranne et pyrydopyranne et procede pour leur preparation | |
| IL147890A0 (en) | Pharmaceutical compositions containing pentafluorobenzenesulfonamide derivatives | |
| DK0577745T3 (da) | Bis-naphtalimider indeholdende amid- og thioamid-forbindelsesstykker som anticancermidler. | |
| BR9608473A (pt) | Complexo organometálico do ferro, composição para o tratamento do paludismo, e, utilização de um composto | |
| BR8504171A (pt) | Derivados de tetra-hidroquinolin-1-ilcarbonilimidazol,processo para sua preparacao,composicoes herbicidas,processo para o combate de ervas daninhas,emprego,processo para a preparacao de composicoes,compostos e processo para sua preparacao |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |